Skip to main content
. Author manuscript; available in PMC: 2023 Mar 1.
Published in final edited form as: Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Aug 19;14(2):e1752. doi: 10.1002/wnan.1752

Figure 2:

Figure 2:

Schematic representation of the mechanism of immunogene therapy by lipid-dendrimer NPs containing siRNA against the immune checkpoint PD-L1 and pDNA encoding the immunostimulating cytokine IL-2. Reprint from Huang et al. 2020.